Beirou-di

Roman name

BayRho-D

Characteristics

Immunologicaki active protein fraction allocated from human plasma or serum donors, the proven absence of antibodies to the human immunodeficiency virus (HIV-1, HIV-2), virus hepatitis C and surface antigen hepatitis B. The drug is made using four effective removal / inactivation of viruses, including сольвент/детергентно��о.Активным of the agent is immunoglobulin G, a single Anti-rh_ | o | (D) -antitela.

Pharmacokinetics

C_max antibodies in the blood is 24 hours; T_1/2 - 4-5 weeks.

Indications

Immunoglobulin rights antiresus Rh_ | o | (D) used in resus-otricationah women not sensitised to the antigen Rh_ | o | (D) (ie, in the absence of resus-antitel) Subject : pregnancy and birth resus-polojitelnogo Child, as artificial and spontaneous abortion, and termination of ectopic pregnancy, the threat of abortion at any time, after the amniocentesis and other procedures associated with the risk of blood falling fruit in the blood of mothers, as well as a trauma abdomen.

Contraindications

Гиперчувствительност ь. Never be mean новорожденным.Введен��е contraindicated resus-polaugitionam rodilnytsam and resus-otricationam rodilnytsam, sencibilizirovannam to antigen Rh_ | o | (D), in the serum are found resus-antitela.

Side-Effects

Reactions to impose immunoglobulin rights antiresus Rh_ | o | (D), there are the people resus-otricationah infrequently and they are primarily in the minor pain at the injection, as well as a slight rise in temperature.

Specific guidance

Children born to women who had received immunoglobulin rights antiresus Rh_ | o | (D) before the birth, at birth to a weak positive results of tests for the presence of antiglobulina. The serum mother may detect antibodies to Rh_ | o | (D), the passive way testa-skrining if the antibodies produced after prenatal or postnatal of immunoglobulin rights antiresus Rh_ | o | (D). immunization women living vaccines should be no earlier than three months after the introduction of immunoglobulin Antiresus.neprigodna to use drugs in vials and syringes in a compromised the integrity or marks when the physical properties (staining, flexible solution Availability nerazbivathan Flakes), in the wrong �ранении.Транспортиро вку have any indoor transport at 2-8 ° C.

Patient interaction

The simultaneous application with other property, in particular antibiotics.

Storage conditions

In the dark place at a temperature of 2-8 ° C

Shelf life

The registration

015375/01

The drug forms

Transparent or slightly opalestirutaya liquid, or diffuse slabo-jeltoi colour without foreign matter. The store allows a minor sludge, vanishing in shaking products at a temperature of 20 ± 2 ° C.

Directory → Immunotropona funds → Immunoglobulins → Beirou-di